Parya Saberi, PharmD

Headshot of Parya Saberi
User Profile Photo

Parya Saberi, PharmD

User Profile Name
Associate Professor, School of Medicine
CTSI Profile Title
User Profile Email

Biography

Parya Saberi, PharmD, MAS is an Assistant Professor at the Center for AIDS Prevention Studies in the Department of Medicine at the University of California, San Francisco. She is also an HIV Clinical Pharmacist at Ward 86 (Positive Health Program) at San Francisco General Hospital. Dr. Saberi's is funded by the National Institute of Mental Health through a K23 Mentored Patient-oriented Research Career Development Award. Her current area of research includes adapting technology-based strategies to improve antiretroviral adherence and engagement in HIV Care among HIV-positive youth. These methods include social networking technologies, video-conferencing tools, and text messaging. Additionally, she is involved in the development of an index of engagement in HIV care as well as research regarding retention and adherence to HIV care in South Africa.

User Profile Bio

Displaying 26 - 50 of 89

  1. Caravella McCuistian, Angie R Wootton, Dominique Legnitto-Packard, Valerie A. Gruber, Carol Dawson-Rose, Mallory O. Johnson, Parya Saberi. Addressing HIV care, mental health and substance use among youth and young adults in the Bay Area: description of an intervention to improve information, motivation and behavioural skills. BMJ Open. 2021 Apr 8; 11(4):e042713.
  2. Caravella McCuistian, Angie R Wootton, Dominique Legnitto-Packard, Valerie A. Gruber, Carol Dawson-Rose, Mallory O. Johnson, Parya Saberi. Addressing HIV care, mental health and substance use among youth and young adults in the Bay Area: description of an intervention to improve information, motivation and behavioural skills. BMJ Open. 2021 Apr 8; 11(4):e042713.
  3. Saberi P, Campbell CK, Venegas M, Dubé K. Time to Engage Young People in HIV Cure Research. AIDS Res Hum Retroviruses. 2021 Apr 01.
  4. Dubé K, Kanazawa J, Dee L, Taylor J, Campbell DM, Brown B, Johnson MO, Saberi P, Sauceda JA, Sugarman J, Peluso MJ. Ethical and practical considerations for mitigating risks to sexual partners during analytical treatment interruptions in HIV cure-related research. HIV Res Clin Pract. 2021 02; 22(1):14-30.
  5. Saberi P, McCuistian C, Agnew E, Wootton AR, Legnitto Packard DA, Dawson-Rose C, Johnson MO, Gruber VA, Neilands TB. Video-Counseling Intervention to Address HIV Care Engagement, Mental Health, and Substance Use Challenges: A Pilot Randomized Clinical Trial for Youth and Young Adults Living with HIV. Telemed Rep. 2021; 2(1):14-25.
  6. Kanazawa JT, Saberi P, Sauceda JA, Dubé K. The LAIs Are Coming! Implementation Science Considerations for Long-Acting Injectable Antiretroviral Therapy in the United States: A Scoping Review. AIDS Res Hum Retroviruses. 2021 02; 37(2):75-88.
  7. Saberi P, Ming K, Scott H, Liu A, Steward W. "You can't have a PrEP program without a PrEP Coordinator": Implementation of a PrEP panel management intervention. PLoS One. 2020; 15(10):e0240745.
  8. Sauceda JA, Neilands TB, Lightfoot M, Saberi P. Findings From a Probability-Based Survey of United States Households About Prevention Measures Based on Race, Ethnicity, and Age in Response to Severe Acute Respiratory Syndrome Coronavirus 2. J Infect Dis. 2020 10 13; 222(10):1607-1611.
  9. Sauceda JA, Neilands TB, Lightfoot M, Saberi P. Findings From a Probability-Based Survey of United States Households About Prevention Measures Based on Race, Ethnicity, and Age in Response to Severe Acute Respiratory Syndrome Coronavirus 2. J Infect Dis. 2020 10 13; 222(10):1607-1611.
  10. Saberi P, Berrean B, Milionis C, Wong JO, Arnold E. We are family: designing and developing a mobile health application for the San Francisco bay area House Ball and Gay Family communities. Mhealth. 2020; 6:42.
  11. Dubé K, Campbell DM, Perry KE, Kanazawa JT, Saberi P, Sauceda JA, Poteat T, Evans D. Reasons People Living with HIV Might Prefer Oral Daily Antiretroviral Therapy, Long-Acting Formulations, or Future HIV Remission Options. AIDS Res Hum Retroviruses. 2020 12; 36(12):1054-1058.
  12. Dubé K, Perry KE, Mathur K, Lo M, Javadi SS, Patel H, Concha-Garcia S, Taylor J, Kaytes A, Dee L, Campbell D, Kanazawa J, Smith D, Gianella S, Auerbach JD, Saberi P, Sauceda JA. Altruism: Scoping review of the literature and future directions for HIV cure-related research. J Virus Erad. 2020 Nov; 6(4):100008.
  13. Saberi P. Research in the Time of Coronavirus: Continuing Ongoing Studies in the Midst of the COVID-19 Pandemic. AIDS Behav. 2020 08; 24(8):2232-2235.
  14. Ming K, Shrestha I, Vazquez A, Wendelborn J, Jimenez V, Lisha N, Neilands TB, Scott H, Liu A, Steward W, Johnson MO, Saberi P. Improving the HIV PrEP continuum of care using an intervention for healthcare providers: a stepped-wedge study protocol. BMJ Open. 2020 07 14; 10(7):e040734.
  15. Koester KA, Saberi P, Fuller SM, Arnold EA, Steward WT. Attitudes about community pharmacy access to HIV prevention medications in California. J Am Pharm Assoc (2003). 2020 Nov - Dec; 60(6):e179-e183.
  16. Saberi P, Eskaf S, Sauceda J, Evans D, Dubé K. Perceptions of HIV Virologic Control Strategies Among Younger and Older Age Groups of People Living with HIV in the United States: A Cross-Sectional Survey. AIDS Res Hum Retroviruses. 2020 07; 36(7):606-615.
  17. Saberi P, Scott HM. On-Demand Oral Pre-exposure Prophylaxis with Tenofovir/Emtricitabine: What Every Clinician Needs to Know. J Gen Intern Med. 2020 04; 35(4):1285-1288.
  18. Saberi P, Chakravarty D, Ming K, Legnitto D, Gandhi M, Johnson MO, Neilands TB. Moving Antiretroviral Adherence Assessments to the Modern Era: Correlations Among Three Novel Measures of Adherence. AIDS Behav. 2020 Jan; 24(1):284-290.
  19. Dubé K, Eskaf S, Evans D, Sauceda J, Saberi P, Brown B, Averitt D, Martel K, Meija M, Campbell D, Barr L, Kanazawa J, Perry K, Patel H, Luter S, Poteat T, Auerbach JD, Wohl DA. The Dose Response: Perceptions of People Living with HIV in the United States on Alternatives to Oral Daily Antiretroviral Therapy. AIDS Res Hum Retroviruses. 2020 04; 36(4):324-348.
  20. Wootton AR, McCuistian C, Legnitto Packard DA, Gruber VA, Saberi P. Overcoming Technological Challenges: Lessons Learned from a Telehealth Counseling Study. Telemed J E Health. 2020 10; 26(10):1278-1283.
  21. Wootton AR, Legnitto DA, Gruber VA, Dawson-Rose C, Neilands TB, Johnson MO, Saberi P. Telehealth and texting intervention to improve HIV care engagement, mental health and substance use outcomes in youth living with HIV: a pilot feasibility and acceptability study protocol. BMJ Open. 2019 07 16; 9(7):e028522.
  22. Reeder C, Neilands TB, Palar K, Saberi P. Food Insecurity and Unmet Needs Among Youth and Young Adults Living With HIV in the San Francisco Bay Area. J Adolesc Health. 2019 08; 65(2):262-266.
  23. Saberi P, Dawson Rose C, Wootton AR, Ming K, Legnitto D, Jeske M, Pollack LM, Johnson MO, Gruber VA, Neilands TB. Use of technology for delivery of mental health and substance use services to youth living with HIV: a mixed-methods perspective. AIDS Care. 2020 08; 32(8):931-939.
  24. Erguera XA, Johnson MO, Neilands TB, Ruel T, Berrean B, Thomas S, Saberi P. WYZ: a pilot study protocol for designing and developing a mobile health application for engagement in HIV care and medication adherence in youth and young adults living with HIV. BMJ Open. 2019 05 05; 9(5):e030473.
  25. Saberi P, Ming K, Legnitto D, Neilands TB, Gandhi M, Johnson MO. Feasibility and acceptability of novel methods to estimate antiretroviral adherence: A longitudinal study. PLoS One. 2019; 14(1):e0210791.